| 1 |
31040646 | Can a cyclooxygenase inhibitor be an option for treatment of ovarian hyperstimulation syndrome? | 2019 |
1 |
| 2 |
27287478 | Hepatic radiofrequency ablation: markedly reduced systemic effects by modulating periablational inflammation via cyclooxygenase-2 inhibition. | 2017 Mar |
1 |
| 3 |
27380212 | Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats. | 2016 Oct |
1 |
| 4 |
24087846 | The effect of celecoxib administration on the healing and neovascularization of colonic anastomosis in rats. | 2014 Jun |
1 |
| 5 |
23922700 | Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesis. | 2013 |
3 |
| 6 |
22256989 | Hydrophilic prodrug approach for reduced pigment binding and enhanced transscleral retinal delivery of celecoxib. | 2012 Mar 5 |
1 |
| 7 |
17121709 | [Chemopreventive effect of celecoxib against DMBA-induced breast cancer and its mechanism]. | 2006 Nov |
4 |
| 8 |
15792788 | Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model. | 2005 Mar 28 |
3 |
| 9 |
15521009 | Up-regulation of the enzymes involved in prostacyclin synthesis via Ras induces vascular endothelial growth factor. | 2004 Nov |
1 |
| 10 |
15553225 | Retinal delivery of celecoxib is several-fold higher following subconjunctival administration compared to systemic administration. | 2004 Oct |
2 |
| 11 |
12504784 | Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model. | 2003 Jan 5 |
4 |